In order to promote the exchange of clinical application of methylation gene testing between Taiwan and China, the Company and Sun Xiang Life Science Co., Ltd. held a seminar on the clinical application of methylation gene testing in Linkou Chang Gung Hospital on October 31, and invited Zhang Tingzhang, Minister of the Department of Obstetrics and Gynecology of Linkou Chang Gung Hospital, to chair the meeting, and Lai Hongzheng, vice president of Shuanghe Hospital, and Professor of Digital from Peking University in China to present research reports and participate in the discussion. This conference was the first cross-strait clinical exchange on methylation gene detection of Cervi-M ® cervical cancer, and the latest clinical application of Cervi-M ® was discussed in the meeting, which also opened a new realm of clinical application of Cervi-M ®. The success of the conference not only made Cervi-M ® a big step forward in clinical and academic practice, but also provided a more effective tool for cervical cancer screening in women, and Cervi-M ® has entered a new milestone in the methylation gene test.
In this seminar, the company showcased the well-known anti-stick product Adept and the latest cervical cancer methylation gene test Cervi-M ®. Thank you for your enthusiastic participation and the kind assistance of our partners!
